Showing 1,546 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

Why do some HIV drugs cost so much in the US? Pharma, insurers, advocacy groups and consumers weigh in

Editor's pick
BETA blog
3 November 2017
Pharmaceutical industry

GSK and Gilead go head to head as HIV drugs enter new phase

Editor's pick
Reuters
2 November 2017
Access to healthcare

MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug

Editor's pick
Intellectual Property Watch
31 October 2017
Pharmaceutical industry

Gilead HCV drug sales down in 2017 third quarter compared with 2016

Editor's pick
Healio
31 October 2017
Pharmaceutical industry

Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty

Editor's pick
Intellectual Property Watch
26 October 2017
Pharmaceutical industry

HIV pills and new lung drugs keep GSK on track in third-quarter

Editor's pick
Reuters
25 October 2017
The search for a cure

The German CEO Pushing for an Immunotherapy to Treat Cancer and HIV

Editor's pick
Labiotech.eu (blog)
23 October 2017
Pharmaceutical industry

Pills and Profits: How drug companies make a killing out of public research

Editor's pick
STOPAIDS
23 October 2017
Types of HIV tests

CE Marking for world’s only integrated HIV Self-Test from Atomo Diagnostics

Editor's pick
Atomo press release
13 October 2017
Generic medicines

Brand Name Vs Generic Drugs: The Fight Continues

Editor's pick
MD Mag
10 October 2017
Pharmaceutical industry

UK pharma denied legal challenge to drugs bill cap

Editor's pick
Pharmaphorum
5 October 2017
Access to healthcare

Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment

Editor's pick
Kaiser Health News
5 October 2017
Pharmaceutical industry

The Hepatitis Drug Market Is Worse Than Wall Street Realises

Editor's pick
Bloomberg
4 October 2017
Access to healthcare

The Medicines Patent Pool and Gilead Sciences Sign Licence for Bictegravir

Editor's pick
Medicines Patent Pool
4 October 2017
New & experimental HIV treatments

Promising HIV Treatments in Late-Stage Clinical Development

Editor's pick
P&T Community
2 October 2017
New & experimental hepatitis C treatment

Is HCV Drug Development Nearing Its End?

Editor's pick
MedPage Today
2 October 2017
Access to healthcare

Unitaid Official Explains How ‘Breakthrough’ HIV Medicine Pricing Deal Brings Best To The Neediest

Editor's pick
Intellectual Property Watch
26 September 2017
Pharmaceutical industry

J&J unit ends hepatitis C drug development in crowded market

Editor's pick
Reuters
11 September 2017
Access to healthcare

Generic PrEP in France and Scotland challenges access across the UK

Editor's pick
HIV i-Base
8 September 2017
Pharmaceutical industry

Did HIV Pharma “Pay to Delay” Generic Truvada?

Editor's pick
Poz
4 September 2017
Pharmaceutical industry

AIDS activists urge N.Y. attorney general to probe Gilead for antitrust violations

Editor's pick
STAT
30 August 2017
Generic medicines

No evidence of reduced efficacy or increased side-effects when patients switch to generic drugs, comparison study finds

News
24 August 2017
Pharmaceutical industry

Bristol-Myers Squibb nixes 58 marketing jobs as HIV medications near patent cliff

Editor's pick
FiercePharma
21 August 2017
Pharmaceutical industry

Gilead's Newer Tenofovir Patents

Editor's pick
Seeking Alpha
15 August 2017